More on SRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (0.9 Score)
- Holders

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Sra International Inc. Cl A (NY:SRX)
Delayed: 31.26 --0 (-0%)
Trade Now!
Prev. Close $31.26  
Open$16.90 
52 Wk High$31.31 
52 Wk Low$18.31 
Day High$31.26 
Day Low$31.26 
P/E 21.56  
EPS$1.45 
Volume2,994,872 

Friends, Peers and Foes (?): SXMDF (more...)

Dec 12, 2016 09:00 AM NCCN Guidelines® Recommend SIR-Spheres® Y-90 Resin microspheres for the Treatment of Metastatic Colorectal Cancer
Nov 15, 2016 05:48 PM Storm Resources Ltd. ("Storm" or the "Company") is Pleased to Announce Its Financial and Operating Results for the Three and Nine Months Ended September 30, 2016
Oct 11, 2016 04:00 AM New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of In
Sep 7, 2016 07:20 PM Storm Resources Ltd. Announces Processing Arrangement at Umbach and Increased 2017 Production Guidance
Aug 25, 2016 09:10 AM Sirtex Medical Inc. Announces 19 Percent Dose Sales Growth of SIR-Spheres® Y-90 resin microspheres in Fiscal Year 2016
Aug 15, 2016 06:07 PM Storm Resources Ltd. ("Storm" or the "Company") Is Pleased to Announce Its Financial and Operating Results for the Three and Six Months Ended June 30, 2016
Jul 1, 2016 03:30 AM Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres® Y-90 resin microspheres, New SIRFLOX Analysis Shows
May 12, 2016 05:06 PM Storm Resources Ltd. Is Pleased to Announce Its Financial and Operating Results for the Three Months Ended March 31, 2016
Mar 31, 2016 06:31 AM SIR-Spheres® Y-90 Resin Microspheres Are a Well-Tolerated Alternative to Standard Therapies for Inoperable Primary Liver Cancer, New UK NICE Medtech Innovation Briefing Says
Mar 16, 2016 11:52 AM Netherlands Healthcare Institute Approves Reimbursement of Selective Internal Radiation Therapy (SIRT) for Patients with Colorectal Liver Metastases Who Have Failed Prior Treatment
View All Articles